Abstract
Mutations in amyloid precursor protein (APP) and presenilin1 result in overproduction and accumulation of β-amyloid (Aβ) peptide, which has been shown to play an important role in Alzheimer’s disease (AD) pathogenesis. Carvedilol, a nonselective β-adrenergic receptor blocker used for treatment for heart failure and hypertension, has displayed its neuroprotective capacity due to its antioxidant property. In this study, we investigated whether Carvedilol has a neuronal protective effect against endogenous Aβ neurotoxicity in mouse Neuro2a (N2a) cells transfected with Swedish amyloid precursor protein (Swe-APP) mutant and Presenilin exon9 deletion mutant (N2a/Swe.D9). Elevated levels of reactive oxygen species (ROS), protein carbonyls, and 4-HNE were found in N2a/Swe.D9 cells, which were ameliorated by administration of Carvedilol in a dose-dependent manner. In addition, the levels of ATP and mitochondrial membrane potential were reduced in N2a/Swe.D9 cells, which were restored by treatment with Carvedilol. N2a/Swe.D9 cells displayed increased vulnerability to H2O2-induced cell death and apoptosis, which could be attenuated by Carvedilol. Mechanistically, we found that Carvedilol prevented apoptosis signals through reducing cytochrome C release and the level of cleaved caspase-3. Taken together, our findings suggest a possible use of Carvedilol in AD treatment.
Similar content being viewed by others
Change history
18 December 2023
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s12192-023-01399-w
References
Arrieta-Cruz I, Wang J, Pavlides C, Pasinetti GM (2010) Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer’s disease. J Alzheimers Dis 21(2):649–654. https://doi.org/10.3233/JAD-2010-100225
Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Evidence of oxidative damage in Alzheimer’s disease brain: central role for amyloid β-peptide. Trends Mol Med 7(12):548–554. https://doi.org/10.1016/S1471-4914(01)02173-6
Carreira R, Duarte A, Monteiro P, Santos MS, Rego AC, Oliveira CR, Gonçalves LM, Providência LA (2004) Carvedilol protects ischemic cardiac mitochondria by preventing oxidative stress. Rev Port Cardiol 23(11):1447–1455
Cotman CW, Su JH (1996) Mechanisms of neuronal death in Alzheimer’s disease. Brain Pathol 6(4):493–506. https://doi.org/10.1111/j.1750-3639.1996.tb00878.x
Glat MJ, Offen D (2013) Cell and gene therapy in Alzheimer’s disease. Stem Cells Dev 22(10):1490–1496. https://doi.org/10.1089/scd.2012.0633
Green R, Reed JC (1998) Mitochondria and apoptosis. Science 281(5381):1309–1312. https://doi.org/10.1126/science.281.5381.1309
Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256(5054):184–185. https://doi.org/10.1126/science.1566067
Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB et al (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21(9):3017–3023
Kumar A, Prakash A, Dogra S (2011) Neuroprotective effect of Carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats. Pharmacol Rep 63(4):915–923. https://doi.org/10.1016/S1734-1140(11)70607-7
LaFerla FM, Oddo S (2005) Alzheimer’s disease: Aβ, tau and synaptic dysfunction. Trends Mol Med 11(4):170–176. https://doi.org/10.1016/j.molmed.2005.02.009
Li-Sha G, Yi-He C, Na-Dan Z, Teng Z, Yue-Chun L (2013) Effects of Carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis. BMC Cardiovasc Disord 13(1):100. https://doi.org/10.1186/1471-2261-13-100
Lysko PG, Lysko KA, Webb CL, Feuerstein G (1992) Neuroprotective effects of Carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor. Neurosci Lett 148(1–2):34–38. https://doi.org/10.1016/0304-3940(92)90798-C
Mattson MP (2004) Pathways towards and away from Alzheimer’s disease. Nature 430(7000):631–639. https://doi.org/10.1038/nature02621
Mohmmad Abdul H, Sultana R, Keller JN, St Clair DK, Markesbery WR, Butterfield DA (2006) Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β-peptide (1-42), H2O2 and kainic acid: implications for Alzheimer's disease. J Neurochem 96(5):1322–1335. https://doi.org/10.1111/j.1471-4159.2005.03647.x
Oliveira PJ, Esteves T, Rolo AP, Palmeira CM, Moreno AJ (2004a) Carvedilol inhibits the mitochondrial permeability transition by an antioxidant mechanism. Cardiovasc Toxicol 4(1):11–20. https://doi.org/10.1385/CT:4:1:11
Oliveira PJ, Bjork JA, Santos MS, Leino RL, Froberg MK, Moreno AJ, Wallace KB (2004b) Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicol Appl Pharmacol 200(2):159–168. https://doi.org/10.1016/j.taap.2004.04.005
Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The U.S. Carvedilol heart failure study group. The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334(21):1349–1355. https://doi.org/10.1056/NEJM199605233342101
Reddy AP, Reddy PH (2017) Mitochondria-targeted molecules as potential drugs to treat patients with Alzheimer’s disease. Prog Mol Biol Transl Sci 146:173–201. https://doi.org/10.1016/bs.pmbts.2016.12.010
Rolo AP, Oliveira PJ, Moreno AJ, Palmeira CM (2003) Chenodeoxycholate induction of mitochondrial permeability transition pore is associated with increased membrane fluidity and cytochrome c release: protective role of Carvedilol. Mitochondrion 2(4):305–311. https://doi.org/10.1016/S1567-7249(03)00007-2
Rosenberg PB, Mielke MM, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG (2008) Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. Am J Geriatr Psychiatry 16(11):883–892. https://doi.org/10.1097/JGP.0b013e318181276a
Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer’s disease. Nature 399(6738 suppl):A23–A31. https://doi.org/10.1038/399a023
Sheng B, Gong K, Niu Y, Liu L, Yan Y, Lu G, Zhang L, Min H, Zhao N, Zhang X, Tang P, Gong Y (2009) Inhibition ofγ-secretase activity reduces Aβproduction, reduces oxidative stress increases mitochondrial activity and leads to reduced vulnerability to apoptosis: implications for the treatment of Alzheimer’s disease. Free Radic Biol Med 46(10):1362–1375. https://doi.org/10.1016/j.freeradbiomed.2009.02.018
Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375(6534):754–760. https://doi.org/10.1038/375754a0
Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer’s disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 94(18):9866–9868. https://doi.org/10.1073/pnas.94.18.9866
Strosznajder RP, Jesko H, Dziewulska J (2005) Effect of Carvedilol on neuronal survival and poly(ADP-ribose) polymerase activity in hippocampus after transient forebrain ischemia. Acta Neurobiol Exp (Wars) 65(2):137–143
Wang L, Wang R, Jin M, Huang Y, Liu A, Qin J, Chen M, Wen S, Pi R, Shen W (2014) Carvedilol attenuates 6-hydroxydopamine-induced cell death in PC12 cells: involvement of Akt and Nrf2/ARE pathways. Neurochem Res 39(9):1733–1740. https://doi.org/10.1007/s11064-014-1367-2
Yamagata K, Ichinose S, Tagami M (2004) Amlodipine and Carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Hypertens Res 27(4):271–282. https://doi.org/10.1291/hypres.27.271
Zuo L, Hemmelgarn BT, Chuang CC, Best TM (2015) The role of oxidative stress-induced epigenetic alterations in amyloid-β production in Alzheimer’s disease. Oxidative Med Cell Longev 2015:604658
Author information
Authors and Affiliations
Corresponding author
Additional information
This article has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1007/s12192-023-01399-w"
Electronic supplementary material
About this article
Cite this article
Liu, J., Wang, M. RETRACTED ARTICLE: Carvedilol protection against endogenous Aβ-induced neurotoxicity in N2a cells. Cell Stress and Chaperones 23, 695–702 (2018). https://doi.org/10.1007/s12192-018-0881-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12192-018-0881-6